04/18/2024
3:16 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form DEFA14A | |
04/18/2024
3:18 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form ARS | |
04/03/2024
3:29 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form PRE 14A | |
03/29/2024
3:30 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio Inc. (Subject)
| Form SC 13G | |
03/05/2024
5:43 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:02 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:14 PM | The Carlyle Group (Subject)
Carlyle Group Inc. (Subject)
Larson Bruce M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/12/2024
5:00 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
02/12/2024
5:23 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:45 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
MKS INSTRUMENTS INC (Subject)
| Form SC 13G/A | |
02/12/2024
4:46 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
ZoomInfo Technologies Inc. (Subject)
| Form SC 13G/A | |
02/12/2024
10:22 AM | The Carlyle Group (Subject)
Carlyle Group Inc. (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
02/08/2024
8:23 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Redett John C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:25 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Ferguson Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:17 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Finn Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:19 PM | Andrews Charles Elliott Jr. (Reporting)
The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:14 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Finn Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:19 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Ferguson Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:44 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
01/03/2024
3:15 PM | The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Partners VII S1 Holdings, L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
CommScope Holding Company, Inc. (Issuer)
TC Group Sub L.P. (Reporting)
TC Group VII S1, L.L.C. (Reporting)
TC Group VII S1, L.P. (Reporting)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
CommScope Holding Company, Inc. (Subject)
| Form SC 13D/A | |
12/19/2023
4:01 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:22 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:23 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
3:36 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
10/16/2023
3:30 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13D/A | |
10/02/2023
6:54 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
SOLENO THERAPEUTICS INC (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
4:18 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Redett John C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2023
3:30 PM | The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Partners VII S1 Holdings, L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
CommScope Holding Company, Inc. (Issuer)
TC Group Sub L.P. (Reporting)
TC Group VII S1, L.L.C. (Reporting)
TC Group VII S1, L.P. (Reporting)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:22 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
Complete Solaria, Inc. (Subject)
Complete Solaria, Inc. (Subject)
Complete Solaria, Inc. (Subject)
| Form SC 13G | |
09/14/2023
3:05 PM | Carlyle Credit Income Fund (Issuer)
The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:05 PM | Carlyle Credit Income Fund (Subject)
The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
| Form SC 13D/A | |
08/30/2023
4:33 PM | Carlyle Credit Income Fund (Issuer)
The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
4:19 PM | Carlyle Credit Income Fund (Subject)
The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
| Form SC 13D/A | |
08/25/2023
5:56 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:15 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13D/A | |
08/18/2023
3:16 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
08/04/2023
3:33 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
08/03/2023
5:08 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Ferguson Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:09 PM | Andrews Charles Elliott Jr. (Reporting)
The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:12 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Larson Bruce M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
3 Sub-$10 Stocks to Buy for 2024 (Ad) Often, investors will overlook stocks just because they're cheap.
It's a common thought that a cheap price tag means that something must be wrong with the company.
But this couldn't be further from the case in many instances. Get your FREE look at these THREE companies right here. |
08/03/2023
5:13 PM | Buser Curtis L. (Reporting)
The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:14 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
Finn Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2023
4:19 PM | Buser Curtis L. (Reporting)
The Carlyle Group (Subject)
Carlyle Group Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
4:21 PM | The Carlyle Group (Subject)
Carlyle Group Inc. (Subject)
Larson Bruce M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
4:23 PM | The Carlyle Group (Subject)
Carlyle Group Inc. (Subject)
Finn Christopher (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
4:25 PM | The Carlyle Group (Subject)
Carlyle Group Inc. (Subject)
Ferguson Jeffrey W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
3:40 PM | Carlyle Credit Income Fund (Subject)
The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
| Form SC 13D/A | |
06/20/2023
6:06 AM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:22 PM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/25/2023
5:20 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:30 PM | Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
The Carlyle Group (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
SOLENO THERAPEUTICS INC (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:32 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13D/A | |
05/09/2023
3:31 PM | The Carlyle Group (Filed by)
Carlyle Group Inc. (Filed by)
Reneo Pharmaceuticals, Inc. (Subject)
| Form SC 13D/A | |
05/03/2023
4:16 PM | The Carlyle Group (Issuer)
Carlyle Group Inc. (Issuer)
HANCE JAMES H JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2023
6:01 AM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2023
6:02 AM | The Carlyle Group (Filer)
Carlyle Group Inc. (Filer)
| Form DEFA14A | |
